IRIS
CASTAGNA, MARIA GRAZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.256
EU - Europa 9.051
AS - Asia 4.252
SA - Sud America 859
Continente sconosciuto - Info sul continente non disponibili 415
AF - Africa 292
OC - Oceania 26
Totale 24.151
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.090
IT - Italia 2.313
RU - Federazione Russa 1.969
SG - Singapore 1.456
GB - Regno Unito 1.420
CN - Cina 1.160
IE - Irlanda 1.133
BR - Brasile 691
SE - Svezia 529
VN - Vietnam 493
FR - Francia 412
HK - Hong Kong 348
DE - Germania 344
UA - Ucraina 261
FI - Finlandia 230
KR - Corea 187
IN - India 173
ZA - Sudafrica 166
NL - Olanda 114
BD - Bangladesh 113
CA - Canada 91
ES - Italia 88
AR - Argentina 61
PL - Polonia 59
TR - Turchia 58
JP - Giappone 43
CI - Costa d'Avorio 33
IQ - Iraq 33
MX - Messico 31
AT - Austria 28
EC - Ecuador 28
MA - Marocco 28
BE - Belgio 27
AU - Australia 24
IR - Iran 23
CZ - Repubblica Ceca 22
CL - Cile 19
ID - Indonesia 19
UZ - Uzbekistan 17
VE - Venezuela 15
KE - Kenya 14
CO - Colombia 13
EG - Egitto 13
NG - Nigeria 13
PK - Pakistan 13
JO - Giordania 12
LT - Lituania 12
NP - Nepal 11
PY - Paraguay 11
RO - Romania 11
SA - Arabia Saudita 11
CH - Svizzera 10
JM - Giamaica 10
PT - Portogallo 9
AE - Emirati Arabi Uniti 8
AL - Albania 8
DZ - Algeria 8
GR - Grecia 8
MY - Malesia 8
PH - Filippine 8
UY - Uruguay 8
BO - Bolivia 7
IL - Israele 7
AZ - Azerbaigian 6
BG - Bulgaria 6
ET - Etiopia 6
KG - Kirghizistan 6
BB - Barbados 5
DO - Repubblica Dominicana 5
LU - Lussemburgo 5
PA - Panama 5
TN - Tunisia 5
CR - Costa Rica 4
EU - Europa 4
KZ - Kazakistan 4
LB - Libano 4
MK - Macedonia 4
OM - Oman 4
PE - Perù 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
AM - Armenia 3
HN - Honduras 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
NI - Nicaragua 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
AO - Angola 2
BH - Bahrain 2
BY - Bielorussia 2
DK - Danimarca 2
GE - Georgia 2
GY - Guiana 2
IM - Isola di Man 2
IS - Islanda 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
Totale 23.714
Salva come PNG Salva come JPEG
Città #
Southend 1.239
Dublin 1.109
Dallas 1.024
Fairfield 749
Singapore 720
Ashburn 701
Santa Clara 569
Moscow 558
San Jose 529
Milan 472
Chandler 420
Woodbridge 332
Hong Kong 331
Wilmington 292
Council Bluffs 284
Houston 282
Seattle 280
Hefei 272
Cambridge 255
Beijing 252
Siena 232
Florence 231
Ann Arbor 217
Los Angeles 192
The Dalles 184
Seoul 180
Jacksonville 178
Rome 178
Ho Chi Minh City 164
New York 154
Johannesburg 152
Lauterbourg 143
Princeton 143
Munich 130
Helsinki 128
Hanoi 111
São Paulo 71
San Mateo 67
Buffalo 63
Shanghai 62
Columbus 58
Orem 55
Nanjing 50
Chicago 45
Turku 44
Bengaluru 42
Redondo Beach 42
San Diego 41
Boardman 40
Chennai 39
London 39
Naples 39
Lappeenranta 38
Málaga 37
Tokyo 35
Turin 35
Warsaw 35
Montreal 34
Abidjan 33
Brooklyn 33
Bologna 31
Dearborn 30
Figino 30
Saint Petersburg 29
Stockholm 28
Düsseldorf 27
Portsmouth 27
Amsterdam 26
Frankfurt am Main 25
Toronto 25
Atlanta 24
Brussels 24
Boston 23
Phoenix 23
Da Nang 22
San Francisco 22
Haiphong 21
Bari 19
Washington 19
Denver 18
Rio de Janeiro 18
Guangzhou 17
Manchester 17
Miami 17
Redwood City 17
Ankara 16
Nuremberg 16
Prato 16
Belo Horizonte 15
Philadelphia 15
Tashkent 15
Vienna 15
Hangzhou 14
Mumbai 14
Tianjin 14
Baghdad 13
Fremont 13
Izmir 13
Palermo 13
Zhengzhou 13
Totale 15.258
Salva come PNG Salva come JPEG
Nome #
CONUT Score: A New Tool for Predicting Prognosis in Patients with Advanced Thyroid Cancer Treated with TKI 489
Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer 382
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 355
DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients 345
Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor 333
Obesity Does Not Modify the Risk of Differentiated Thyroid Cancer in a Cytological Series of Thyroid Nodules 327
Rare POMC Mutation in a Patient With Myotonic Dystrophy Type 1 and Adrenocorticotropin Hyperresponse to Corticotropin-Releasing Hormone 326
G-protein coupled receptors (GPCRs) in the treatment of diabetes: Current view and future perspectives 308
Reference range of serum calcitonin in pediatric population 307
Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes 301
Nodules in autoimmune thyroiditis are associated with increased risk of thyroid cancer in surgical series but not in cytological series: evidence for selection bias 301
Approach to and treatment of differentiated thyroid carcinoma 299
FASTING ENHANCES TKI EFFICACY ON THYROID CANCER CELLS 293
Acute exogenous TSH administration stimulates leptin secretion in vivo 282
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 279
Large-scale screening of organ specific autoantibodies in patients with autoimmune thyroid diseases 276
One month weight loss predicts the efficacy of liraglutide in obese patients: Data from a single center 274
Analytical performance of free testosterone calculated by direct immunoluminometric method compared with the Vermeulen equation: results from a clinical series 270
Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients 266
Clinical significance of type 2 iodothyronine deiodinase polymorphism 262
Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients 253
MicroRNA expression profile of thyroid nodules in fine-needle aspiration cytology: a confirmatory series 249
Dual energy CT in gland tumors: a comprehensive narrative review and differential diagnosis 248
Role of age at diagnosis in defining potential familial nonmedullary thyroid cancer in kindreds with two affected members 246
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 233
Alteration of Serum Proteome in Levo-Thyroxine-Euthyroid Thyroidectomized Patients 231
SEX HORMONES IN LONG QT SYNDROME AND TORSADES DE POINTES (TDP) 229
Paradoxical effect of dopamine-agonists on IGF-1 in patients with prolactinoma: the role of weight 229
Variants in MCT10 protein do not affect FT3 levels in athyreotic patients 228
Calcitonin Levels in Thyroid Disease Are Not Affected by Autoimmune Thyroiditis or Differentiated Thyroid Carcinoma 226
Autoimmune thyroid diseases are more common in patients with prolactinomas: a retrospective case–control study in an Italian cohort 224
Screening and detecting significant liver fibrosis in patients with NAFLD: A practical approach using non-invasive tests 224
Prospective Validation of ATA and ETA Sonographic Pattern Risk of Thyroid Nodules Selected for FNAC 223
Validation of American Thyroid Association Ultrasound Risk-Adapted Approach for Repeating Cytology in Benign Thyroid Nodules 223
Assessing the Prevalence of Male Obesity-Associated Gonadal Dysfunction in Severe Obesity: A Focus on the Impact of Bariatric Surgery and Surgical Approaches 220
Medullary thyroid carcinoma 220
BROX haploinsufficiency in familial nonmedullary thyroid cancer 219
Monitoraggio del nodulo tiroideo benigno in accordo con la classe di rischio ecografica 213
Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patients 212
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 211
Long-Term Clinical Outcome in Familial and Sporadic Papillary Thyroid Carcinoma 207
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes 205
Controlling Nutritional Status (CONUT) Score and Micronutrient Deficiency in Bariatric Patients: Midterm Outcomes of Roux-en-Y Gastric Bypass Versus One Anastomosis Gastric Bypass/Mini Gastric Bypass 205
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 204
New specific skeletal muscle mass index cut-offs for the assessment of sarcopenia in patients with severe obesity 203
Molecular signature of indeterminate thyroid lesions: Current methods to improve fine needle aspiration cytology (FNAC) diagnosis 202
Should familial disease be considered as a negative prognostic factor in micropapillary thyroid carcinoma? 202
Silent thyroiditis following vaccination against COVID-19: report of two cases 200
HABP2 G534E variation in familial non-medullary thyroid cancer: an Italian series 199
Preliminary results from whole-genome expression analysis in patients with secondary adrenal insufficiency treated with modified-release hydrocortisone 199
Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients 198
Risk of second malignant neoplasm in familial non-medullary thyroid cancer patients 197
Pilot study on the impact of polymorphisms linked to multi-kinase inhibitor metabolism on lenvatinib side effects in patients with advanced thyroid cancer 196
Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy 195
Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study 190
Normalization of Spexin Levels in Patients with Obesity Submitted to Bariatric Surgery 188
From Circulating Tumor Cells to Mirna: New Challenges in the Diagnosis and Prognosis of Medullary Thyroid Cancer 188
Il carcinoma familiare non midollare della tiroide non sindromico 186
8th edition of the AJCC/TNM staging system of thyroid cancer: What to expect (ITCO#2) 186
Tireotossicosi in gravidanza e nel post-partum 185
Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a novel missense mutation in AVP gene in a large Italian kindred 185
Incidental findings of anti-mitochondrial antibodies without evidence of Primary Biliary Cholangitis. 183
Effects of Acute Recombinant Human TSH on Serum Ghrelin Levels 181
A case of papillary thyroid cancer without aggressive histological features with nodal metastases detected during follow-up in a younger patients 179
Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients 175
Dynamic Risk Stratification Integrated with ATA Risk System for Predicting Long-Term Outcome in Papillary Thyroid Cancer 173
Response Letter to the Editor from Edmundo Avila-Hipolito: "Long-term effects of radioiodine in toxic multinodular goitre: thyroid volume, function and autoimmunity" 173
A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer 171
Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal. 171
Radioiodine therapy in the different stages of differentiated thyroid cancer 170
Pregnancy-associated plasma protein A mRNA expression as a marker for differentiated thyroid cancer: results from a "surgical" and a "cytological" series 170
Prognostic Factors Improving ATA Risk System and Dynamic Risk Stratification in low and Intermediate DTC Patients 170
Screening of organ-specific autoantibodies in a large cohort of patients with autoimmune thyroid diseases. 169
Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study 167
New insight in the follow-up strategies of differentiated thyroid cancer 164
Exploring the Susceptibility to Multiple Primary Tumors in Patients with Differentiated Thyroid Cancer 163
Nodular Thyroid Disease in the Era of Precision Medicine 163
Familial non-medullary thyroid cancer: a critical review 163
Attention deficit and hyperactivity disorders in the offspring of mothers exposed to mild-moderate iodine deficiency: A possible novel iodine deficiency disorder in developed countries 162
Features and outcome of differentiated thyroid carcinoma associated with Graves’ disease: results of a large, retrospective, multicenter study 161
Effect of Pre-Existent Sarcopenia on Oncological Outcome of Advanced Thyroid Cancer Patients Treated with Tyrosine Kinase Inhibitors 158
Improvement of overall survival using TKIs as salvage therapy in advanced thyroid carcinoma: Real‐life data on a single center experience 157
Permanent diabetes insipidus in a patient with mesothelioma treated with immunotherapy 157
A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study 156
Long-term Effects of Radioiodine in Toxic Multinodular Goiter: Thyroid Volume, Function, and Autoimmunity 156
Type 2 deiodinase p.Thr92Ala polymorphism does not affect the severity of obesity and weight loss after bariatric surgery 155
Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels 150
Eif1ax c.338-2a>t splice site mutation in a patient with trabecular adenoma and cytological indeterminate lesion 150
Indication for radioiodine remnant ablation in differentiated thyroid cancer patients: does 2018 Italian consensus change anything? 150
Correction: Circulating miR‑26b‑5p and miR‑451a as diagnostic biomarkers in medullary thyroid carcinoma patients 149
Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma 149
Associazione Americana di Endocrinologia Clinica e Associazione Medici Endocrinologi: algoritmo per la diagnostica dei noduli tiroidei 148
The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma 148
Thr92Ala polymorphism in the type 2 deiodinase gene: an evolutionary perspective 136
A case of papillary thyroid cancer without aggressive histological features with nodal metastyases in an older patients 135
Real-world performance of ATA risk estimates in predicting 1-year DTC outcomes: A prospective multicenter study of 2000 patients (ITCO Study #3) 134
Changes in both size and cytological features of thyroid nodule after levothyroxine treatment 133
In response to the letter to the editor by Soha Ghanian et al. re our publication “Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males” 132
PAPPA expression in indeterminate thyroid nodules as screening test to select patients for molecular testing 132
Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy 132
Totale 21.101
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.491
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.491
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.238 0 110 110 141 78 85 38 51 80 149 167 229
2022/20231.787 109 218 219 200 132 365 78 123 168 68 54 53
2023/20241.979 67 48 161 123 138 407 666 78 43 39 44 165
2024/20254.124 93 183 476 273 468 302 161 206 458 210 403 891
2025/20269.405 700 1.108 861 1.197 1.622 328 1.135 365 298 476 458 857
2026/2027871 519 352 0 0 0 0 0 0 0 0 0 0
Totale 24.151